Psychosocial interventions for suicidal children and adolescents

2001 ◽  
Vol 14 (3) ◽  
pp. 192-197 ◽  
Author(s):  
Mary A. Fristad ◽  
Amy E. Shaver
Keyword(s):  
Children And Adolescents ◽  
Psychosocial Interventions

scholarly journals Psychosocial Interventions for School Refusal Behavior in Children and Adolescents

2009 ◽  
Vol 3 (1) ◽  
pp. 11-20 ◽  
Author(s):  
Armando A. Pina ◽  
Argero A. Zerr ◽  
Nancy A. Gonzales ◽  
Claudio D. Ortiz
Keyword(s):  
Children And Adolescents ◽  
Psychosocial Interventions ◽  
School Refusal ◽  
School Refusal Behavior

Depression in Children and Adolescents

2005 ◽  
Vol 21 (6) ◽  
pp. 311-317 ◽  
Author(s):  
Noel M. Davis
Keyword(s):  
Risk Factors ◽  
Academic Performance ◽  
Social Development ◽  
Children And Adolescents ◽  
Diagnostic Criteria ◽  
Nursing Practice ◽  
Early Recognition ◽  
Psychosocial Interventions ◽  
School Nursing ◽  
The Past

During the past 20 years, depression has been recognized widely in children and adolescents. However, even with what is known today about depression, many children and adolescents remain undiagnosed. Early recognition is imperative to prevent further episodes that may continue into adulthood. Depression in children and adolescents affects social development, academic performance, and ultimately, success as an adult. This article describes risk factors for depression, diagnostic criteria, medications, psychosocial interventions, and implications for school nursing practice.

scholarly journals eHealth and mHealth Psychosocial Interventions for Youths With Chronic Illnesses: Systematic Review

10.2196/22329 ◽  
2020 ◽  
Vol 3 (2) ◽  
pp. e22329
Author(s):  
Nancy Lau ◽  
Shayna Waldbaum ◽  
Ryan Parigoris ◽  
Alison O'Daffer ◽  
Casey Walsh ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Mental Health Problems ◽  
Digital Health ◽  
Meta Analysis ◽  
Psychosocial Interventions ◽  
Chronic Illnesses ◽  
Significant Heterogeneity ◽  
Discussion Forums ◽  
Medical Diagnoses ◽  
Efficacy Studies

Background An estimated 12.8% of children and adolescents experience chronic health conditions that lead to poor quality of life, adjustment and coping issues, and concurrent mental health problems. Digital health deployment of psychosocial interventions to support youth with chronic illness has become increasingly popular with the advent of the technological advances in the digital age. Objective Our objectives were to systematically review published efficacy studies of eHealth and mHealth (mobile health) psychosocial interventions for youths with chronic illnesses and review intervention theory and treatment components. Methods PubMed, Embase, Web of Science, PsycInfo, and Cochrane Database of Systematic Reviews were searched for studies published from 2008 to 2019 of eHealth and mHealth psychosocial interventions designed for children and adolescents with chronic illnesses in which efficacy outcomes were reported. We excluded studies of interventions for caregivers, healthy youth, disease and medication management, and telehealth interventions that function solely as a platform to connect patients to providers via phone, text, or videoconference. Results We screened 2551 articles and 133 relevant full-text articles. Sixteen efficacy studies with psychosocial and health outcomes representing 12 unique interventions met the inclusion criteria. Of the included studies, 12 were randomized controlled trials and 4 were prospective cohort studies with no comparison group. Most interventions were based in cognitive behavioral theory and designed as eHealth interventions; only 2 were designed as mHealth interventions. All but 2 interventions provided access to support staff via text, phone, email, or discussion forums. The significant heterogeneity in intervention content, intervention structure, medical diagnoses, and outcomes precluded meta-analysis. For example, measurement time points ranged from immediately postcompletion of the mHealth program to 18 months later, and we identified 39 unique outcomes of interest. The majority of included studies (11/16, 69%) reported significant changes in measured health and/or psychosocial posttreatment outcomes, with small to large effect sizes. Conclusions Although the available literature on the efficacy of eHealth and mHealth psychosocial interventions for youth with chronic illnesses is limited, preliminary research suggests some evidence of positive treatment responses. Future studies should continue to evaluate whether digital health platforms may be a viable alternative model of delivery to traditional face-to-face approaches.

Psychosocial Treatments for Conduct Disorder in Children and Adolescents

2015 ◽  
Author(s):  
Alan E. Kazdin
Keyword(s):  
Family Therapy ◽  
Conduct Disorder ◽  
Children And Adolescents ◽  
Psychosocial Interventions ◽  
Management Training ◽  
Parent Management Training ◽  
Strategic Family Therapy ◽  
Multidimensional Treatment Foster Care ◽  
Long Term Impact ◽  
Brief Strategic Family Therapy

Significant advances have been made in the treatment of antisocial and aggressive behavior (conduct disorder), a severe source of impairment among children and adolescents. Several psychosocial interventions with strong evidence in their behalf with children and adolescents are highlighted in the chapter. They include parent management training, multisystemic therapy, multidimensional treatment foster care, cognitively based treatments, functional family therapy, brief strategic family therapy, and the Good Behavior Game. The treatments have been very well studied, with multiple replications. There remain questions about the long-term impact of treatments, the persons for whom one or more of these treatments are well suited, and how to optimize therapeutic change.

scholarly journals Prevalence of multimodal treatment in children and adolescents with ADHD in Germany: a nationwide study based on health insurance data

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Oliver Riedel ◽  
Simon Klau ◽  
Ingo Langner ◽  
Christian Bachmann ◽  
Oliver Scholle
Keyword(s):  
Children And Adolescents ◽  
Multimodal Treatment ◽  
Treatment Options ◽  
Psychosocial Interventions ◽  
Health Claims ◽  
Health Insurance Data ◽  
Psychotherapeutic Treatment ◽  
Psychiatric Comorbidities ◽  
Treatment Status ◽  
Health Claims Data

Abstract Background Attention-deficit hyperactivity disorder (ADHD) ranks top among neurodevelopmental disorders in children and adolescents. Due to a large number of unfavorable outcomes including psychiatric comorbidities, school problems, and lower socioeconomic status, early and effective treatment of ADHD is essential. Multimodal treatment has become the gold standard in ADHD management, comprising pharmacotherapy and psychosocial interventions, e.g., psychotherapy. Yet, little is known about the prevalence of multimodal treatment in routine care. Methods Based on German health claims data for the years 2009–2017, we identified children and adolescents aged 3–17 years diagnosed with ADHD and characterized them cross-sectionally (per calendar year) in terms of treatment status and psychiatric comorbidities. The detection of pharmacotherapy was based on dispensations of drugs to treat ADHD (e.g., methylphenidate); psychotherapeutic treatment was based on corresponding billing codes. Multimodal treatment was assumed if ADHD medication and psychotherapeutic treatment were coded within the same calendar year. Psychiatric comorbidities were based on outpatient and inpatient diagnoses. Prevalences of ADHD and proportions of different treatment options were calculated and standardized by age and sex. Results In 2017, 91,118 children met the study criteria for ADHD (prevalence: 42.8/1000). Of these, 25.2% had no psychiatric comorbidity, 28.8% had one, 21.6% had two, and 24.5% had three or more. Regarding overall treatment status, 36.2% were treated only pharmacologically, 6.5% received multimodal treatment, and 6.8% were treated with psychotherapy only (neither treatment: 50.2%). With increasing numbers of psychiatric comorbidities, the proportions of patients with multimodal treatment increased from 2.2% (no psychiatric comorbidities) to 11.1% (three or more psychiatric comorbidities) while the proportions of untreated (from 56.8% to 42.7%) or only pharmacologically treated patients (38.4% to 35.0%) decreased. From 2009 to 2017, prevalences were stable and the proportion of patients with only pharmacotherapy decreased from 48% to 36.5%. Concurrently, the proportion of patients with neither pharmacotherapy nor psychotherapy increased from 40.5% to 50.2%. The fraction of patients with multimodal treatment ranged between 6.5% (2017) and 7.4% (2013). Conclusions Multimodal treatment, although recommended as the standard of treatment, is rather the exception than the rule. It is, however, increasingly common in ADHD patients with psychiatric comorbidities.

Sign in / Sign up

Export Citation Format

Share Document